Balancing efficacy with tolerability: The conversational mechanics of shared decision making in metastatic castration-resistant prostate cancer (mCRPC). Background: Dose volume specific endpoints ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback